Alzheimer's Drug Discovery Foundation logo
Funder · Foundation

Alzheimer's Drug Discovery Foundation

Funds Alzheimer's-focused drug-discovery teams through mission-driven investments and philanthropic collaboration for earlier-stage breakthroughs.

Global / Multinationalwww.alzdiscovery.org
Key stats
Annual funding—
Programs8
Active grants3
Total grants6
About

The Alzheimer's Drug Discovery Foundation is a New York-based 501(c)(3) foundation founded in 1998 by Leonard A. Lauder and Ronald A. Lauder. It funds Alzheimer's and related-dementia work worldwide, and it says it has distributed nearly $400 million across 792 programs in 21 countries.

Its programs center on drug development, biomarkers, prevention, diagnostics, and frontotemporal-dementia work.…

Programs & grants under this funder
Accelerating Drug Discovery for FTD RFP

Funds early translational drug discovery for frontotemporal degeneration globally.

1 grant
Accelerating Drug Discovery for FTD RFP
Closed
— pool
The Treat FTD Fund

Backs clinical trials for frontotemporal degeneration with milestone-based funding and expert oversight.

1 grant
Treat FTD Fund
Closed
— pool
Neuroimaging and CSF Biomarker RFP

Supports biomarker projects that improve diagnosis, imaging, or trial design for Alzheimer's disease.

1 grant
ADDF Neuroimaging and CSF Biomarker RFP
Open
— pool·25 days
Diagnostics Accelerator

Funds Alzheimer's disease biomarker and diagnostic tools for earlier, easier, and more accurate detection.

Drug Development RFP

Funds early-stage drug development and first human testing for Alzheimer's disease and related dementias.

1 grant
ADDF Drug Development RFP
Open
— pool·25 days
ADDF-Harrington Scholar Program

Supports academic drug discovery projects in the United States, Canada, and United Kingdom.

1 grant
ADDF-Harrington Scholar Program
Between cycles
— pool
Prevention RFP

Funds prevention studies designed to delay or prevent Alzheimer's disease before symptom onset.

1 grant
ADDF Prevention RFP
Open
— pool·25 days
ADDF Drug Development Awards

Supports Alzheimer drug discovery teams guiding candidates from early biology studies to readiness for clinical steps.

Last verified: 28 May 2026Source: www.alzdiscovery.org